Aethlon Medical Inc
NASDAQ:AEMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Aethlon Medical Inc (AEMD) under the Base Case is 0.58 USD per share.
Compared with the current market price of 5.46 USD, the stock appears
Overvalued by 89% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Aethlon Medical Does
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 9 full-time employees. The firm is focused on advancing the Hemopurifier (HP), a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and organ transplantation and other areas of significant unmet needs.
- Headquarters
- United States of America US
- Employees
- 9
- IPO date
- Mar 9, 1994
Balance Sheet
Continue AEMD Research
Decided on Aethlon Medical? Get an email when AEMD reaches the price you’d buy at. Free with an account.
Other Aethlon Medical listings
What is the Intrinsic Value of one AEMD stock?
The intrinsic value for
Aethlon Medical Inc (AEMD) under the Base Case is 0.58 USD.
Is AEMD stock undervalued or overvalued?
Compared with the current market price of 5.46 USD, the stock appears Overvalued by 89% .